2 most recent filings and news items mentioning CORT. Updated every 60 seconds.
RegulatoryJun 17, 2026Positive
Corcept Therapeutics resubmitted its New Drug Application to the FDA for relacorilant, incorporating additional data analyses requested by the agency, with an expected six-month review timeline. The resubmission is based on positive Phase III trial data showing the drug provides
View filing at SEC.gov →
OptionsJun 9, 2026Neutral
7 Health Care Stocks With Whale Alerts In Today's Session
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.